Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elena Vinuesa-Pitarch
Institution:
Josep Carreras Leukaemia Research Institute
Observed institution:
Josep Carreras Leukaemia Research Institute
ORCID:
0000-0002-3989-2494
Observed ORCID:
0000-0002-3989-2494
OpenAlex ID:
A5032350660
How Lineage Tracing Studies Can Unveil Tumor Heterogeneity in Breast Cancer
2021
·
Elena Vinuesa-Pitarch
, Daniel Ortega-Álvarez
, et al.
·
Biomedicines
·
8
PDF
Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
·
Cancer Research
·
5
PDF
Supplementary Figure S7 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Figure 5 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Supplementary Figure S3 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Supplementary Figure S2 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Supplementary Figure S4 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Supplementary Figure S11 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Figure 4 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Figure 3 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Figure 6 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Figure 1 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Supplementary Table S3 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Supplementary Table S2 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Figure 2 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Supplementary Figure S5 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Supplementary Table S5 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Supplementary Figure S9 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Supplementary Figure S8 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Supplementary Figure S6 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Supplementary Table S4 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Supplementary Figure S10 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Supplementary Figure S1 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Data from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Figure 7 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies
2026
·
Daniel Ortega-Álvarez
, David Tébar-García
, et al.
Show more works
View as search
Works count:
26
Citation count:
13
H-index:
2
I10-index:
Year
Topic
Type